Table 1 Summary of samples processed in the study
Sample type | Technologies | Samples | Cells that pass QC |
|---|---|---|---|
GL261 | Microfluidic snRNA-Seq | 10x nuclei GL261-1 | 3.333 |
10x nuclei GL261-2 | 960 | ||
Microfluidic scRNA-Seq | 10x cells GL261-1 | 3.951 | |
10x cells GL261-2 | 4.641 | ||
FACS-based scRNA-Seq | FACS GL261-1 | 235 | |
FACS GL261-2 | 545 | ||
FACS GL261-3 | 549 | ||
GL261-GSCs | Microfluidic snRNA-Seq | 10x nuclei GL261-GSCs-1 | 3.198 |
10x nuclei GL261-GSCs-2 | 2.289 | ||
10x nuclei GL261-GSCs-3 | 1.782 | ||
Microfluidic scRNA-Seq | 10x cells GL261-GSCs-1 | 3.402 | |
10x cells GL261-GSCs-2 | 5.605 | ||
10x cells GL261-GSCs-3 | 7.025 | ||
10x cells GL261-GSCs-4 | 4.03 | ||
FACS-based scRNA-Seq | FACS GL261-GSCs-1 | 464 | |
FACS GL261-GSCs-2 | 213 | ||
FACS GL261-GSCs-3 | 188 | ||
FACS GL261-GSCs-4 | 237 | ||
Tissue | Microfluidic snRNA-Seq | Early control-1 | 4.727 |
Early control-2 | 4.451 | ||
Late control-1 | 4.207 | ||
Late control-2 | 3.886 | ||
Early peptide-1 | 3.365 | ||
Early peptide-2 | 5.554 | ||
Early peptide-3 | 4.499 | ||
Late peptide-1 | 1.314 | ||
Early TMZ-1 | 5.154 | ||
Early TMZ-2 | 2.728 | ||
Early TMZ-3 | 3.774 | ||
Late TMZ-1 | 648 | ||
Late TMZ-2 | 1.109 | ||
Late TMZ-3 | 5.156 |
